Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0 - Wikidata - awgldk - TriplyDB

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

http://www.wikidata.org/entity/Q27486402

about

Hepatitis C genotype 6: A concise review and response-guided therapy proposal Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice Hepatitis C virus: Virology, diagnosis and treatment HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes.A novel hepatitis C virus genotyping method based on liquid microarray Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.HCV infection among Saudi population: high prevalence of genotype 4 and increased viral clearance rate Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping Evaluation of multiplex nested polymerase chain reaction for routine hepatitis C virus genotyping in egyptian patients Evaluation of the Abbott Real Time HCV genotype II assay for Hepatitis C virus genotyping.Distribution of Hepatitis C Virus Genotypes in Bahrain.High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.Important factors in reliable determination of hepatitis C virus genotype by use of the 5' untranslated region Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6.Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging.Systematic review: epidemiology of hepatitis C genotype 6 and its management.Systematic review: Asian patients with chronic hepatitis C infection.Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6.Diagnosis and Management of Hepatitis C Virus Infection.APASL consensus statements and management algorithms for hepatitis C virus infection.Hepatitis C Genotype Prevalence in Monastir Region, Tunisia: Correlation between 5' Untranslated Region (5'UTR), Non-structural 5B (NS5B), and Core Sequences in HCV Subtyping.Advances in the Diagnosis and Monitoring of Hepatitis C Virus Infection.Molecular characterization of hepatitis C virus core region in moroccan intravenous drug users.Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs.SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells.Hepatitis C Virus Genotype and Subtype Distribution in Patient Specimens Tested at the University of Texas Medical Branch, Galveston, Between January 2011 and November 2014.Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing.Virology analyses of HCV genotype 4 isolates from patients treated with simeprevir and peginterferon/ribavirin in the Phase III RESTORE study.Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal.Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence.Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: novel insights about targeted genotyping approaches.Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay.Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping.Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping.

P2860

Q22305417-926FF070-F8EA-4AAF-8847-A141CBBCF433 Q27490447-7083C807-FCE2-42B5-98DE-7C2BB4A0AA45 Q28082000-24D563EF-3D8A-4C3B-9EF4-A08982897196 Q28545256-0E19E2D1-E117-4A95-8B7A-B2B155186697 Q28652352-03F3323D-E7D6-4610-8CD0-B2DE4698398A Q33645428-DA886BED-C8C8-4393-A510-3C64442234EB Q33700325-4950DB37-C124-428F-B0C6-615C0A5C69AE Q34008754-0CF7CBC2-06F9-4D3B-BC94-009859722D04 Q34130628-94470AAD-BE8D-489B-A373-FBB978B7A7F8 Q34298265-770D7B5D-CD1C-47A5-A26E-F4108024DF3E Q35455627-5E06CCBD-36A0-4573-A495-47131A63CAD2 Q35990080-9EF28D1E-C925-47C7-8ED4-1E4C3568E23B Q36270128-55F7FDB7-6D28-4D15-9997-CA12CFF5965B Q36639886-5EB5D0E4-6355-42CE-BDB7-3AC6365C4A9F Q36676315-32124B4C-9EEB-4A16-828D-068C89B84C85 Q36702487-74FA46B0-2A2D-4810-81B8-6466B053DFE9 Q36826804-96A80C13-61EC-4A4A-B0EE-6F96743CB5FB Q37040485-096274E0-E184-40D7-8424-AFDC9CCCD533 Q37125237-8A2FDE81-929C-41C3-981B-F51E9E160074 Q37286221-1C95C3A0-2CD2-4FF4-9A21-3EFAD5216B7F Q37682493-76D1700F-565A-43CB-9A40-811EBABAFCBB Q37882006-AA9B49EE-587A-4BA8-A526-E00D58BC64A1 Q38096012-B90D8D25-A705-49EC-9F7D-4C904F959620 Q38164114-425CDBBB-89E9-400C-B1C6-B8C427325B34 Q38327430-309271FB-9E17-4C07-A4E5-2D7177ECE50B Q38552131-EBFCC29B-5BE6-4043-863A-A39B32A6D2D0 Q38866070-9BA0CC15-A2D7-42A8-B92E-9D0CD4E706DE Q38992041-006FE43F-C3BF-4063-8A91-74A98A1658F6 Q39533745-FDB7031B-FD15-4862-AEE5-734A7279FF53 Q39641275-60115358-F145-4082-8014-607AB957D33A Q39791492-5DAF03DC-C94D-4934-BE84-B8F09E6BD4D1 Q39904754-2278E869-680E-45C2-BF00-07D65663F12D Q40419604-F0DE6639-6075-4A40-B418-0688BB5BAA1D Q40518926-9ACAF1A1-97E5-44F7-8607-18D953539CB9 Q40857029-7E1DE9E9-FA7C-49C5-91BE-2A5305AB63C3 Q41829739-9D02A34B-91B4-4080-A16F-E00D107B51CE Q42205040-97F3B966-151B-411F-B2A7-15AAFD4889B1 Q42270437-DC90D735-AD13-4858-BD85-6ABB1E21AE7A Q42716855-7B8119F9-4C6E-4CAF-BCAE-8343C5A16110 Q42994500-BD131B9B-09DC-410A-A8AD-79ED5AE34188

P2860

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

http://www.wikidata.org/entity/Q27486402

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

@ast

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

@en

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

@nl

type

label

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

@ast

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

@en

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

@nl

prefLabel

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

@ast

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

@en

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

@nl

P1433

Q27486402-0AE94474-A7AF-4737-A6D1-5C04FB76823C

P1476

Q27486402-1C876A65-3499-4B9A-8F67-26A4ABF2B6AC

P2093

Q27486402-2043B559-D900-4632-834B-1EBF8A6D15EA

Q27486402-330FAA2A-556E-4324-BF5D-289D9120A77F

Q27486402-39E32691-495D-4228-955A-5E50315AEBDF

Q27486402-6002D59D-374F-4E73-AD38-39B8AF57ADBD

Q27486402-807931BF-B4AB-4CFD-ACD6-4218404B1158

Q27486402-918AAF5E-F523-4F1A-B0CB-6B6F2C1CDD2E

Q27486402-A6BA0F30-54B5-4C45-A53E-DC1216F9151E

Q27486402-AEA7AC50-D0C5-47E2-ABE7-86A786CC49D0

Q27486402-DCA97E7F-1C50-44F6-8866-EC98C626A945

Q27486402-FEF083EF-B8BA-4ECC-B279-FC2FE921022F

P2860

Q27486402-1797660D-2B4B-46B7-B3A9-DA66539815B4

Q27486402-182C5C43-FCC4-4D44-B9C5-AAF69048CED8

Q27486402-18FBCBF5-B92F-40C8-94E4-5864232C5E28

Q27486402-1A4076C7-6BAF-46AA-B6DC-2068A8462496

Q27486402-21A78FCD-2358-4D0A-BD22-15BC1AA526E2

Q27486402-2EEC123E-07F0-4635-8B30-BD11C25333DB

Q27486402-31EA6215-FDA4-4CC8-81DC-1FC708F9C4E1

Q27486402-381FC48C-DB76-45AF-9DE5-BCDCD726507A

Q27486402-3C105081-A156-4997-948A-A22C6750FD6D

Q27486402-460F2125-A599-4799-A097-84664A7AC2EF

P304

Q27486402-A2CE3055-3095-43A1-BA3C-F9F841D10374

P31

Q27486402-19DB5C3C-AB74-42C1-81B4-E7DEA951F094

P3181

Q27486402-5B1C1D80-D135-4FC5-AC35-0F50A3CE57F4

P356

Q27486402-261B6CE3-B3F1-4B37-A855-510453172D73

P407

Q27486402-E9909BA4-0687-46E5-A327-DA1D88654A69

P433

Q27486402-7DC78D02-8528-4973-B0BC-467A34023059

P478

Q27486402-032D6577-4B8B-448C-9254-43F66125F9EA

P50

Q27486402-131134A8-B05F-4255-B50F-F7C448421DCB

Q27486402-58E6F5DB-2A26-4F5C-843A-81EBC068CEE4

Q27486402-85524BCB-5896-4151-9109-B428B35F7221

Q27486402-EACE2EB9-E9C2-4B9A-BF4E-6E1ECD9E1F3F

P577

Q27486402-F06360A6-B225-4530-92DC-F07ED01B18BD

P5875

Q27486402-E336DD54-844E-45A6-83C1-90C3731359C8

P698

Q27486402-C9359AC3-8D8D-4B35-A0BF-F4084EA77E54

P932

Q27486402-EE651B5D-6900-49DD-A356-A1D2F9DEF091

P3181

P356

P1433

Journal of Clinical Microbiology

P1476

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

@en

P2093

Alice Farrior

http://www.w3.org/2001/XMLSchema#string

Carl Schaper

http://www.w3.org/2001/XMLSchema#string

Els Huyck

http://www.w3.org/2001/XMLSchema#string

Jen Shieh

http://www.w3.org/2001/XMLSchema#string

Judy Morimoto

http://www.w3.org/2001/XMLSchema#string

Linda Celis

http://www.w3.org/2001/XMLSchema#string

Margaret Jankowski-Hennig

http://www.w3.org/2001/XMLSchema#string

Marianne Van Brussel

http://www.w3.org/2001/XMLSchema#string

Mark J Stanley

http://www.w3.org/2001/XMLSchema#string

Pamela Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b

Investigating the Origin and Spread of Hepatitis C Virus Genotype 5a

Clinical Evaluation of Two Methods for Genotyping Hepatitis C Virus Based on Analysis of the 5' Noncoding Region

Laboratory Assays for Diagnosis and Management of Hepatitis C Virus Infection

Genotyping Hepatitis C Viruses from Southeast Asia by a Novel Line Probe Assay That Simultaneously Detects Core and 5' Untranslated Regions

Subtyping of hepatitis C virus isolates by a line probe assay using hybridization

Second-generation line probe assay for hepatitis C virus genotyping

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

P304

1901-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3935690

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JCM.02390-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

Jannick Verbeeck

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5451660

http://www.w3.org/2001/XMLSchema#string

P698

18400913

http://www.w3.org/2001/XMLSchema#string

P932

2446848

http://www.w3.org/2001/XMLSchema#string